The Europe artificial intelligence (AI) in healthcare market is projected to reach USD 31.72 billion by 2030 from USD 6.12 billion in 2025, at a CAGR of 39.0% during the forecast period. Market growth is driven by strong government-led digital transformation initiatives, the increasing adoption of Al-enabled diagnostics and clinical decision support across hospitals, and the rising demand for automation to address workforce shortages in Europe's healthcare systems. Additionally, advancements in imaging Al, predictive analytics, and interoperable data platforms are accelerating the large-scale deployment of Al solutions across the region. However, market expansion is restrained by fragmented healthcare infrastructures and the complexities of complying with evolving regulations such as the EU Al Act and GDPR.
The prominent players operating in the Europe artificial intelligence (AI) in healthcare market include Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US), GE Healthcare (US), Medtronic (US), Oracle (US), Merative (IBM) (US), Google (US), Cognizant (US), Johnson & Johnson (US), Amazon Web Services, Inc. (US), SOPHiA GENETICS (US), Solventum Corporation (US), Tempus (US), and Viz.ai (US). These companies adopted various strategies, including product launches, updates, expansions, partnerships, collaborations, mergers, and acquisitions, to strengthen their market presence in the Europe artificial intelligence (AI) in healthcare market.
To know about the assumptions considered for the study download the pdf brochure
Koninklijke Philips N.V. (Netherlands)
Koninklijke Philips N.V. is a leading player in the Europe artificial intelligence (Al) in healthcare market as the company utilizes Al to deliver innovative tools across various areas, including diagnostic imaging, patient monitoring, and precision medicine. Its advanced Al-driven platforms, such as Philips HealthSuite, facilitate the integration and analysis of extensive clinical data, which support personalized treatment plans and improve patient outcomes. Philips focuses on organic and inorganic growth strategies to expand its market presence. Strategic partnerships in high-potential markets and collaborations have been the key growth strategies of the company over the years. For example, in February 2025, the company partnered with Medtronic to educate and train cardiologists and radiologists in India on advanced imaging techniques for the diagnosis and treatment of structural heart diseases. This partnership aims to upskill over 300 clinicians in multi-modality imaging, including echocardiography (ECHO) and Magnetic Resonance Imaging (MRI), particularly for patients with end- stage renal disease (ESRD). In November 2023, Philips and NYU Langone Health collaborated to prioritize patient safety and outcomes. This partnership integrated innovative health technologies, including digital pathology, clinical informatics, and Al-enabled diagnostics, enabling real-time collaboration among clinicians. The company also focuses on winning contracts across several companies in the healthcare space. This helps the company expand its footprint. For instance, in September 2022, Philips and Mandaya Royal Hospital Puri (MRHP) in Jakarta initiated a strategic partnership that resulted in a digital transformation that enhanced patient-centered care and healthcare services.
Microsoft Corporation (US)
Microsoft Corporation is one of the leading providers of software & tools that include advanced Al capabilities in healthcare to improve patient outcomes, streamline operations, and drive innovation. Its Azure-based Al solutions support various applications, including medical imaging, genomics, and precision medicine. The company also provides healthcare-specific Al models through its Azure Al Model Catalog, which is constructed to support hospitals and research institutions in building and deploying tailored Al solutions proficiently. Moreover, the integration of Nuance's Al-powered clinical and diagnostic tools encourages its capacity to support healthcare providers in decision-making and care delivery. The company continually integrates Al capabilities into its platforms, utilizing large-scale customer models. For instance, in March 2025, the company launched Microsoft Dragon Copilot, the first unified voice Al assistant in the healthcare industry, which enables clinicians to streamline clinical documentation, surface relevant information, and automate tasks. Microsoft Corporation has invested significantly in R&D, which has enhanced its product portfolio and market position in the Al sector. Machine Learning (ML), deep learning, Natural Language Processing (NLP), and speech processing are the key focus areas of the company in the Al in healthcare market. The company continuously invests in a series of services and computational biology projects, including research support tools for next- generation precision healthcare, genomics, immunomics, CRISPR, and cellular and molecular biologics. It has a strong presence in Europe, with key operations supported through its Azure cloud infrastructure across Europe countries.
MARKET RANKING
The ranking of companies in the Europe artificial intelligence (Al) in healthcare market has been determined through a market share analysis conducted after extensive secondary research and validated by primary respondents across key Europe countries. This ranking reflects parameters such as regional revenue contribution from Al in healthcare and the breadth and depth of product portfolios tailored to European clinical needs, regulatory readiness, and the pace of innovation and solution deployment. Based on this assessment, the leading players in the Europe market include Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), GE HealthCare (US), NVIDIA Corporation (US), and Microsoft Corporation (US). These companies leverage strong R&D capabilities and deep integration with European healthcare systems and also continuous advancements in imaging Al, workflow orchestration, analytics, and cloud-based solutions.
Koninklijke Philips N.V. stands out as a dominant player in the Europe Al in healthcare space with extensive deployments in diagnostic imaging, patient monitoring, and precision medicine across national health systems. Siemens Healthineers benefits from its strong regional footprint, robust clinical partnerships, and advanced Al-powered imaging and diagnostic platforms, which are specifically designed for Europe's diverse healthcare infrastructure. Microsoft Corporation maintains a strong presence in Europe through its Azure cloud ecosystem and healthcare Al tools, which enhance clinical decision-making, streamline operations, and support digital transformation initiatives. The company strengthens its presence through strategic collaborations with hospitals, research institutions, and technology partners across Europe by enabling scalable and compliant deployments that align with GDPR and EU Al Act requirements. These combined strengths position these companies at the forefront of Europe's rapidly expanding Al in healthcare market.
Related Reports:
Europe Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Telehealth, RPM, Immunotherapy, Supply Chain), Application (Clinical), End User (Hospitals) - Forecast to 2030
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE